Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 1
2020 7
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Impact of COVID-19 mitigations on anxiety and depression amongst university students: A systematic review and meta-analysis.
Lee B, Krishan P, Goodwin L, Iduye D, de Los Godos EF, Fryer J, Gallagher K, Hair K, O'Connell E, Ogarrio K, King T, Sarica S, Scott E, Li X, Song P, Dozier M, McSwiggan E, Stojanovski K, Theodoratou E, McQuillan R; UNCOVER group. Lee B, et al. J Glob Health. 2023 Sep 1;13:06035. doi: 10.7189/jogh.13.06035. J Glob Health. 2023. PMID: 37655370 Free PMC article.
Clinical features of COVID-19 for integration of COVID-19 into influenza surveillance: A systematic review.
Lee B, Ashcroft T, Agyei-Manu E, Farfan de los Godos E, Leow A, Krishan P, Kulkarni D, Nundy M, Hartnup K, Shi T, McSwiggan E, Nair H, Theodoratou E, McQuillan R; Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. Lee B, et al. J Glob Health. 2022 Apr 14;12:05012. doi: 10.7189/jogh.12.05012. J Glob Health. 2022. PMID: 35567582 Free PMC article. Review.
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis.
Lee B, Lewis G, Agyei-Manu E, Atkins N, Bhattacharyya U, Dozier M, Rostron J, Sheikh A, McQuillan R, Theodoratou E; Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. Lee B, et al. Eur Respir Rev. 2022 Nov 2;31(166):220066. doi: 10.1183/16000617.0066-2022. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36323417 Free PMC article. Review.
20 results